(IN BRIEF) On October 1, 2024, Andrea Six reported on the groundbreaking work by EMPA researchers in collaboration with Aldena Therapeutics to develop nanoceramic “stars” for treating common skin conditions like psoriasis and neurodermatitis. These nanoceramic structures temporarily create micro-wounds … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged ANDREA SIX, Empa, innovative, Nanoceramics, neurodermatitis, psoriasis, Skin Disease Treatment
Cosentyx (secukinumab) met the primary endpoints of superiority compared to placebo in patients with difficult-to-treat psoriasis of the nails, palms and soles[1],[2] One third of patients with moderate-to-severe palmoplantar psoriasis achieved clear or almost clear skin on their palms and … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Cosentyx, Novartis, psoriasis, Vasant Narasimhan
16-8-2013 — /EuropaWire/ — Immunologists at LMU have come up with a new technique that can be used both to fight tumors and to treat autoimmune diseases. A new grant from the Federal Ministry for Education and Research will enable the … Read the full press release
Posted in Education, Germany, Healthcare, Pharma & Biotech, Science
Tagged autoimmune disease, autoimmune diseases, BMBF, Clinical Neuroimmunology, Cytotoxic T cells, fight tumors, LMU, multiple sclerosis, pathogen-derived protein fragments, peptides, Privatdozent Dr. Klaus Dornmair, Prof. Jörg Prinz, psoriasis, T cells, treat autoimmune diseases, tumor-specific antigens, tumors, Validation of the Innovation Potential of Scientific Research
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?